SUBSCRIBE
SUBSCRIBE
News   Business

VasoGenix Pharmaceuticals, Inc. Elects Former AVAX Technologies, Inc. CEO Richard P. Rainey to Its Board of Directors

February 3, 2009 | 
1 min read
LENEXA, Kan.--(BUSINESS WIRE)--VasoGenix Pharmaceuticals announced today that Richard P. Rainey, CPA, former CEO of Avax Technologies, a publicly traded biotechnology company, has been elected to its board of directors.
People
MORE ON THIS TOPIC
Handmade signboard with Closed inscription and striped rope hanging on pin on bright red background
Company closure
Bespoke Startup EveryONE Folds 1 Week After Plausible Mechanism Guidance
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail
March 4, 2026
 · 
61 min read
 · 
BioSpace Editorial Staff
Halftone hands reaching for money. Mixed media catch falling coins and cash bills collage, financial success, free wealth and easy money concept vector illustration
Earnings
Keytruda Hangs On to Best Seller Crown as GLP-1s Gain Ground
March 4, 2026
 · 
9 min read
 · 
Tristan Manalac
Set of crumpled lumps of different paper isolated on yellow background. Gritty dusty dotted effect, vector elements with jagged edges, old notebook sheets.
MASH
Boehringer Ingelheim Axes MASH Pact With OSE After Disappointing Mid-Stage Data
March 3, 2026
 · 
2 min read
 · 
Tristan Manalac